ARHGEF12, TRIM13 and APC had no differential expression between the normal and tumor samples at stage1 while RASSF2, RECK, and CBFA2T3 shows much lower expression in the tumor samples at stage1 than in the normal samples with p < 0.007 (Supplementary Fig. S2a). This evidence concerns the gene RASSF2 and neoplasm.